GLAXOSMITHKLINE PLC's ticker is GSK and the CUSIP is 37733W105. A total of 783 filers reported holding GLAXOSMITHKLINE PLC in Q2 2017. The put-call ratio across all filers is 0.75 and the average weighting 0.3%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2019 | $354,000 | +2.6% | 7,965 | -7.7% | 0.09% | +9.9% |
Q2 2019 | $345,000 | -29.0% | 8,631 | -25.8% | 0.08% | -24.3% |
Q1 2019 | $486,000 | +2.3% | 11,631 | -6.4% | 0.11% | -12.3% |
Q4 2018 | $475,000 | -22.1% | 12,425 | -18.1% | 0.12% | -12.9% |
Q3 2018 | $610,000 | -91.1% | 15,179 | -91.1% | 0.14% | -91.6% |
Q2 2018 | $6,857,000 | -32.5% | 170,097 | -34.6% | 1.67% | -31.4% |
Q1 2018 | $10,158,000 | +46.3% | 259,993 | +32.8% | 2.43% | +37.9% |
Q4 2017 | $6,943,000 | -46.2% | 195,744 | -38.4% | 1.76% | -47.2% |
Q3 2017 | $12,899,000 | -3.6% | 317,703 | +2.4% | 3.34% | -6.6% |
Q2 2017 | $13,378,000 | +33.8% | 310,248 | +30.8% | 3.57% | +23.7% |
Q1 2017 | $10,002,000 | +83.5% | 237,234 | +67.6% | 2.89% | +75.8% |
Q4 2016 | $5,451,000 | -4.2% | 141,554 | +7.3% | 1.64% | -3.4% |
Q3 2016 | $5,690,000 | +96.3% | 131,919 | +97.3% | 1.70% | +87.3% |
Q2 2016 | $2,898,000 | +57860.0% | 66,866 | +57050.4% | 0.91% | +45250.0% |
Q2 2015 | $5,000 | -91.4% | 117 | -90.6% | 0.00% | -91.3% |
Q1 2015 | $58,000 | – | 1,250 | – | 0.02% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Sio Capital Management, LLC | 325,823 | $11,557,000 | 6.52% |
KAHN BROTHERS GROUP INC | 1,139,163 | $40,406,111,000 | 6.35% |
Chubb Ltd | 400,000 | $14,188,000 | 6.18% |
Healthcare Value Capital, LLC | 50,000 | $1,774,000 | 5.40% |
CLARK ESTATES INC/NY | 650,000 | $23,056,000 | 3.81% |
PVG ASSET MANAGEMENT CORP | 220,450 | $7,819,361,000 | 3.57% |
Martin Capital Partners, LLC | 88,195 | $3,128,000 | 3.25% |
Camber Capital Management LP | 1,500,000 | $53,205,000 | 2.60% |
EQUITY INVESTMENT CORP | 2,090,120 | $74,137,000 | 2.47% |
Keystone Financial Planning, Inc. | 129,102 | $4,579,000 | 2.44% |